Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
References
- Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation. 2019; 139(10): e56–e528.
- Kralev S, Schneider K, Lang S, Süselbeck T, Borggrefe M. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PloS one. 2011; 6(9):
e24964 . DOI: 10.1371/journal.pone.0024964 - Correction to: 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019; 140(6): e285. DOI: 10.1161/CIR.0000000000000719
- Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014; 64(24): e139–e228. DOI: 10.1016/j.jacc.2014.09.017
- Lopes RD, Rao M, Simon DN, Thomas L, Ansell J, Fonarow GC, et al. Triple vs dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. The American Journal of Medicine. 2016; 129(6): 592–9.e1. DOI: 10.1016/j.amjmed.2015.12.026
- Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice.
Clinical Practice Guidelines We Can Trust . In: Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, (eds.). Washington, DC: National Academies Press (US) Copyright 2011 by the National Academy of Sciences. All rights reserved. 2011. - Makarski J, Brouwers MC. The AGREE Enterprise: a decade of advancing clinical practice guidelines. Implementation science: IS. 2014; 9: 103. DOI: 10.1186/s13012-014-0103-2
- Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Preventive medicine. 2010; 51(5): 421–4. DOI: 10.1016/j.ypmed.2010.08.005
- Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182(18): E839–E42. DOI: 10.1503/cmaj.090449
- Hoffmann-Eßer W, Siering U, Neugebauer EAM, Lampert U, Eikermann M. Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research & Evaluation II instrument-a third of AGREE II users apply a cut-off for guideline quality. Journal of clinical epidemiology. 2018; 95: 120–7. DOI: 10.1016/j.jclinepi.2017.12.009
- He WM, Luo YT, Shui X, Liao XX, Liu JL, Zhuang XD. Critical appraisal of international guidelines on chronic heart failure: Can China AGREE? International journal of cardiology. 2016; 203: 111–4. DOI: 10.1016/j.ijcard.2015.10.105
- Chen Y, Yang K, Norris SL. Managing conflicts of interest in practice guidelines panels. JAMA. 2017; 318(9): 866–7. DOI: 10.1001/jama.2017.9672
- Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–962. DOI: 10.1093/eurheartj/ehw210
- Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J; 2019.
- Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018; 39(3): 213–60. DOI: 10.1093/eurheartj/ehx419
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1; 42(5): 546–547. DOI: 10.1093/eurheartj/ehaa945
- (UK) NCGC. Secondary prevention in primary and secondary care for patients following a myocardial infarction Royal College of Physicians; 2013.
- O’Gara PT, Kushner FG, Ascheim DD, Casey DE,
Jr. , Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127(4): e362–425. - Amsterdam EA, Wenger NK, Brindis RG, Casey DE,
Jr. , Ganiats TG, Holmes DR,Jr. , et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 130(25): e344–426. DOI: 10.1161/CIR.0000000000000134 - Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018; 154(5): 1121–201. DOI: 10.1016/j.chest.2018.07.040
- January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC,
Jr. , et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019; 140(2): e125–e51. DOI: 10.1161/CIR.0000000000000665 - Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, et al. 2018 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. Can J Cardiol. 2018; 34(11): 1371–92. DOI: 10.1016/j.cjca.2018.08.026
- Mehta SR, Bainey KR, Cantor WJ, Lordkipanidze M, Marquis-Gravel G, Robinson SD, et al. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy. Can J Cardiol. 2018; 34(3): 214–33. DOI: 10.1016/j.cjca.2017.12.012
- Chew DP, Scott IA, Cullen L, French JK, Briffa TG, Tideman PA, et al. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ. 2016; 25(9): 895–951. DOI: 10.1016/j.hlc.2016.06.789
- Group NCAFGW, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ. 2018; 27(10): 1209–66. DOI: 10.1016/j.hlc.2018.06.1043
- Group JCSJW. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J. 2014; 78(8): 1997–2021. DOI: 10.1253/circj.CJ-66-0092
- Chiang CE, Wu TJ, Ueng KC, Chao TF, Chang KC, Wang CC, et al. 2016 guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. J Formos Med Assoc. 2016; 115(11): 893–952. DOI: 10.1016/j.jfma.2016.10.005
- Li YH, Wang YC, Wang YC, Liu JC, Lee CH, Chen CC, et al. 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome. J Formos Med Assoc. 2018; 117(9): 766–90. DOI: 10.1016/j.jfma.2018.06.002
- Molino CdGRC, Leite-Santos NC, Gabriel FC, Wainberg SK, Vasconcelos LPd, Mantovani-Silva RA, et al. Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: A systematic review. JAMA Intern Med. 2019; 179(4): 553–60. DOI: 10.1001/jamainternmed.2018.7529
- JM vdH, AM H, HR B, AK M-T, A dB, journal M-vdZAJT. NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands. 2018; 16: 7. DOI: 10.1186/s12959-017-0156-y
DOI: https://doi.org/10.5334/gh.1104 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 4, 2022
Accepted on: Jan 17, 2022
Published on: Feb 23, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Yongqiang Fan, Gaoxing Zhang, Zhengzhipeng Zhang, Shaozhao Zhang, Menghui Lin, Yifen Lin, Yiquan Huang, Xiangbin Zhong, Xiaodong Zhuang, Xinxue Liao, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.